Director Andrews Patricia S bought ONCY shares on the open market once in the last year, totaling about $30,300, with the latest purchase on February 12, 2026. This ranks her 3415th among 4983 insiders by purchase value, below the average of $1.46 million across 3.29 transactions. She reported no open market sales of Oncolytics Biotech Inc. shares.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 25, 2026 | GERON CORP | $GERN | Andrews Patricia S | Not found | A | Stock Option (Right to Buy) | 270000 | $0.00 | 270,000.0000 | 667,101,756 | 9999.99% | 0.04% |
| Feb. 12, 2026 | ONCOLYTICS BIOTECH INC | $ONCY | Andrews Patricia S | Director | P | Common Shares | 35400 | $0.86 | 78,128.0000 | 80,020,131 | 82.85% | 0.04% |
| May 1, 2024 | CRESCENT BIOPHARMA, INC. | $CBIO | Andrews Patricia S | Not found | A | Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 29, 2023 | CRESCENT BIOPHARMA, INC. | $CBIO | Andrews Patricia S | Director | A | Common stock | 5191 | $2.36 | 58,608.0000 | 0 | 9.72% | 0.00% |